Skip to main content

Month: May 2024

Abercrombie & Fitch Co. to Report First Quarter 2024 Results on May 29, 2024

NEW ALBANY, Ohio, May 03, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Wednesday, May 29, 2024, at 8:30 a.m. ET. A press release detailing the company’s first quarter results is expected to be issued shortly after 7:30 a.m. ET. In addition, a presentation of the first quarter results will be available on the company’s website at approximately 7:30 a.m. ET.Conference Call: To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link.   Webcast: To listen to a live webcast of the call, please visit corporate.abercrombie.com/investors/news-and-events/events/ and click the link to the webcast.   Replay: A replay of the...

Continue reading

Applied Digital Announces Appointment of Datacenter Industry Expert Todd Gale as Chief Development Officer

Todd Gale to Lead the Company’s Datacenter Design Strategy, Leveraging Over 45 Years of Industry Experience DALLAS, May 03, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (“HPC”) applications, today announced that Todd Gale has been appointed as Chief Development Officer, effective May 3, 2024. Mr. Gale’s wealth of leadership acumen, developed during his tenure at Flexential and Terremark Worldwide, equips him to lead pivotal initiatives in his new role, propelling the growth and innovation of Applied Digital’s HPC datacenter campus in Ellendale, North Dakota. His focus on designing liquid cooling systems, optimizing power systems...

Continue reading

Ocuphire Pharma to Present at the Aegis Virtual Conference

FARMINGTON HILLS, Mich., May 03, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today announced that George Magrath, M.D. M.B.A., M.S., Chief Executive Officer of Ocuphire, will present a company overview at the Aegis Virtual Conference being held May 7-9, 2024. Company management will also be participating in one-on-one meetings throughout the conference. Key details about Dr. Magrath’s presentation at the Aegis Capital Virtual Conference are below: Aegis Capital Virtual Conference – May 7-9, 2024Title of Presentation: Ocuphire Pharma, Inc. (OCUP) Company PresentationPresenter: George Magrath, M.D. M.B.A, M.S.Date: Wednesday, May 8, 2024Time: 3:00 – 3:25pm ET   If...

Continue reading

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

MIAMI, May 03, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.)...

Continue reading

Belo Sun Mining Announces Changes to Executive Leadership

TORONTO, May 03, 2024 (GLOBE NEWSWIRE) — Belo Sun Mining Corp. (“Belo Sun” or the “Company” (TSX: BSX, OTCRB: BSXGF) announces a change in leadership in which Mr. Peter Tagliamonte, President and CEO, has left the Company with immediate effect. Ms. Ayesha Hira, currently an Independent Director of the Company, will serve as Interim President and CEO while a search is conducted to recruit a permanent President and CEO. Executive Chairman, Mr. Mark Eaton said, “The Company continues to face challenges at its Volta Grande project (“VGP”) in Brazil and the Board is confident that Ayesha Hira’s leadership will help energize the Company and will also provide a new perspective on and approach to advancing VGP through a complex regulatory process in a highly litigious environment. Ayesha’s commitment to take on this role reaffirms our...

Continue reading

IES Holdings Reports Fiscal 2024 Second Quarter Results

HOUSTON, May 03, 2024 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter ended March 31, 2024. Second Quarter 2024 Highlights and Recent DevelopmentsRevenue of $706 million for the second quarter of fiscal 2024, an increase of 24% compared with $569 million for the same quarter of fiscal 2023 Operating income of $77.7 million for the second quarter of fiscal 2024, an increase of 146% compared with $31.6 million for the same quarter of fiscal 2023 Net income attributable to IES of $52.9 million for the second quarter of fiscal 2024, an increase of 146% compared with $21.6 million for the same quarter of fiscal 2023, and diluted earnings per share attributable to common stockholders of $2.29 for the second quarter of fiscal 2024, compared with $0.92...

Continue reading

Uniti to Merge with Windstream Creating Premier Insurgent Fiber Provider

Scaled Platform and Differentiated Focus on Tier II and III Markets De-levered Balance Sheet and Cash Flow Generation to Support Growth Additional Value Creation Opportunities Include up to $125 Million of Targeted Annual Opex and Capex Synergies and Enhanced Strategic Optionality LITTLE ROCK, Ark., May 03, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it has entered into a definitive agreement to merge with Windstream Holdings II, LLC (“Windstream”). Under the terms of the agreement, which have been unanimously approved by both companies’ Board of Directors, upon closing, Uniti shareholders will hold approximately 62% of the outstanding common equity of the combined company and Windstream shareholders will hold approximately 38% of the outstanding common equity. The merger combines Uniti’s...

Continue reading

Shenandoah Telecommunications Company Reports First Quarter 2024 Results

EDINBURG, Va., May 03, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced first quarter 2024 financial and operating results. Tower segment’s financial results will be presented as discontinued operations in the Company’s Consolidated Financial Statements. Under the new organizational and reporting structure, the Company has one reportable segment in continuing operations. First Quarter 2024 HighlightsGlo Fiber Markets added approximately 5,000 subscribers and ended the quarter with approximately 47,000 subscribers. Glo Fiber passings grew 25,700 to a total of approximately 260,000. As previously reported, Shentel completed the initial closing of the sale of substantially all of Shentel’s tower portfolio and operations (“Tower Portfolio”) to Vertical Bridge Holdco,...

Continue reading

GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1 2025 Phase 2a clinical trial of GH001 in postpartum depression on track for expected completion in Q3 2024 Cash, cash equivalents, other financial assets and marketable securities of $214.0 million expected to provide cash runway into 2026DUBLIN, Ireland, May 03, 2024 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the first quarter ended March 31, 2024, and provided updates on its business. Business Updates GH001 in Patients with TRD GH001, our proprietary inhaled mebufotenin...

Continue reading

Rapid Micro Biosystems Reports First Quarter 2024 Financial Results

Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million, representing growth of at least 20% compared to full year 2023 LOWELL, Mass., May 03, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2024. Recent HighlightsFirst quarter total revenue (combined product and service revenue) increased 11% to $5.6 million First quarter recurring revenue increased 15% to $3.7 million, including record consumable revenue Placed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.